Dávid Maliňák

Dr. Dávid Maliňák

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 November 2015 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
Eugenie  NepovimovaEugenie Nepovimova
Eugenie Nepovimova
Jan KorabecnyJan Korabecny
Jan Korabecny
RDRafael Doležal
Rafael Doležal
KBKaterina Babkova
Katerina Babkova
AOAles Ondrejicek
Ales Ondrejicek
Kamil KucaKamil Kuca
Kamil Kuca

31 August 2016 in Archives of Toxicology
Verified
Journal Article
Closed access
PDF file
LGLukas Gorecki
Lukas Gorecki
Jan KorabecnyJan Korabecny
Jan Korabecny
KMKamil Musilek
Kamil Musilek
DMDávid Maliňák
Dávid Maliňák
Eugenie  NepovimovaEugenie Nepovimova
Eugenie Nepovimova
Kamil KucaKamil Kuca
Kamil Kuca

1 November 2018 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
TZTamara Zorbaz
Tamara Zorbaz
DMDávid Maliňák
Dávid Maliňák
NMNikola Maraković
Nikola Maraković
NHNikolina Maček Hrvat
Nikolina Maček Hrvat
AZAntonio Zandona
Antonio Zandona
KMKamil Musilek
Kamil Musilek

1 January 2018 in Journal of Enzyme Inhibition and Medicinal Chemistry
Verified
Journal Article
Open access
EMEva Mezeiova
Eva Mezeiova
KSKatarina Spilovska
Katarina Spilovska
Eugenie  NepovimovaEugenie Nepovimova
Eugenie Nepovimova
LGLukas Gorecki
Lukas Gorecki
Ondrej SoukupOndrej Soukup
Ondrej Soukup
Jan KorabecnyJan Korabecny
Jan Korabecny
Alzheimer’s disease is debilitating neurodegenerative disorder in the elderly. Current therapy relies on administration of acetylcholinesterase inhibitors (AChEIs) -donepezil, rivastigmine, galantamine, and N-methyl-d-aspartate receptor antagonist memantine. However, their therapeutic effect is only short-term and stabilizes cognitive functions for up to 2 years. Given this drawback together with other pathological hallmarks of the disease taken into consideration, novel approaches have recently emerged to better cope with AD onset or its progression. One such strategy implies broadening the biological profile of AChEIs into so-called multi-target directed ligands (MTDLs). In this review article, we made comprehensive literature survey emphasising on donepezil template which was structurally converted into plethora of MTLDs preserving anti-cholinesterase effect and, at the same time, escalating the anti-oxidant potential, which was reported as a crucial role in the pathogenesis of the Alzheimer’s disease. Graphical Abstract

1 October 2016 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
RDRafael Doležal
Rafael Doležal
OSOndrej Soukup
Ondrej Soukup
DMDávid Maliňák
Dávid Maliňák
RSRanylson M.L. Savedra
Ranylson M.L. Savedra
JMJan Marek
Jan Marek
Kamil KucaKamil Kuca
Kamil Kuca

1 November 2014 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
DMDávid Maliňák
Dávid Maliňák
RDRafael Doležal
Rafael Doležal
JMJan Marek
Jan Marek
SSSarka Salajkova
Sarka Salajkova
OSOndrej Soukup
Ondrej Soukup
Kamil KucaKamil Kuca
Kamil Kuca